Related Experiment Video

Updated: Jul 12, 2025

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.6K

Gene of the month: cancer testis antigen gene 1b (NY-ESO-1)

Max Julve1, Oliver Kennedy2, Adam Enver Frampton3,4

  • 1Department of Surgery and Cancer, Imperial College London, London, UK maximilian.julve@nhs.net.

Journal of Clinical Pathology
|October 19, 2023
PubMed

Insights

Cancer testis antigen gene 1B (CTAG1B), also known as New York oesophageal squamous carcinoma 1 (NY-ESO-1), is a promising target for cancer immunotherapy. Research explores its potential in novel vaccines and engineered cell therapies for oncology.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Cancer testis antigens (CTAs), including CTAG1B/NY-ESO-1, exhibit restricted expression and can trigger immune responses.
  • NY-ESO-1's unique characteristics make it a compelling target for developing novel cancer immunotherapies.

Purpose of the Study:

  • To review the structure, function, and detection of CTAG1B/NY-ESO-1.
  • To discuss advances in immunotherapeutic strategies targeting CTAG1B/NY-ESO-1 for cancer treatment.

Main Methods:

  • Literature review of studies on CTAG1B/NY-ESO-1.
  • Analysis of immunohistochemical detection methods.
  • Evaluation of emerging immunotherapeutic approaches, including cancer vaccines and engineered cellular therapies.

Main Results:

  • CTAG1B/NY-ESO-1 plays a role in both healthy and diseased states.
  • Various immunotherapies targeting CTAG1B/NY-ESO-1 are under development, showing early promise.
  • Early clinical trials indicate potential for durable responses and future applications.

Conclusions:

  • CTAG1B/NY-ESO-1 is a significant target for cancer immunotherapy development.
  • Novel therapeutic strategies like cancer vaccines and engineered cell therapies show potential.
  • Further research and clinical trials are essential to establish efficacy and integrate these therapies into practice.
Keywords:
CANCERTESTIS

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.3K
Teratoma Generation in the Testis Capsule05:24

Teratoma Generation in the Testis Capsule

Published on: November 7, 2011

20.8K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.6K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K